Literature DB >> 26820938

Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.

Tao Wang1, Zi Liu2, Fan Shi2, Jiquan Wang2.   

Abstract

The prolyl isomerase Pin1, which is frequently highly expressed in many different cancers, can directly regulate cell proliferation and the cell cycle. However, the role of Pin1 in chemo-resistance remains to be elucidated in cervical cancer. The purpose of the present study was to investigate the role of Pin1 in the chemo-resistance of cervical cancer. The cisplatin resistance was assessed using the MTT assay. Pin1, FoxM1, β-catenin, Cyclin D1, and c-myc expression levels were detected by RT-qPCR or Western blot. The results showed that Pin1 expression displayed a similar expression pattern with the resistance to cisplatin in five cervical cell lines. Knockdown of Pin1 significantly increased the sensitivity to cisplatin in HeLa cells, while Pin1 overexpression decreased the sensitivity to cisplatin in Me180 cells. Knockdown of Pin1 significantly down-regulated FoxM1 expression in HeLa cells, while Pin1 overexpression showed a contrary effect in Me180 cells. Besides, overexpression of Pin1 markedly increased the protein expression of β-catenin and its target genes cyclin D1 and c-myc. FoxM1 siRNA remarkably reversed the promotory effect of pcDNA-Pin1(+) on β-catenin and its target genes cyclin D1 and c-myc in Me180 cells. Furthermore, we also found that FoxM1 siRNA and IWP-2 markedly decreased cell viability, and IWP-2 decreased cell viability to the maximum extent in the Me180 cells co-transfected with pcDNA-Pin1(+) and FoxM1 siRNA. Taken together, these data suggest that Pin1 contributes to cisplatin resistance, partly by up-regulating FoxM1 and Wnt/β-catenin signaling pathway involved in cervical cancer.

Entities:  

Keywords:  Cervical cancer; Chemo-resistance; Cisplatin; FoxM1; Pin1

Mesh:

Substances:

Year:  2016        PMID: 26820938     DOI: 10.1007/s11010-015-2651-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma.

Authors:  Roberta Pang; John Yuen; Man Fung Yuen; Ching Lung Lai; Terence K W Lee; Kwan Man; Ronnie T P Poon; Sheung Tat Fan; Chun M Wong; Irene O L Ng; Yok Lam Kwong; Eric Tse
Journal:  Oncogene       Date:  2004-05-20       Impact factor: 9.867

Review 2.  The emerging roles of forkhead box (Fox) proteins in cancer.

Authors:  Stephen S Myatt; Eric W-F Lam
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

3.  FOXM1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and mediates sensitivity to cisplatin in A549 cells via the JNK/mitochondrial pathway.

Authors:  Y Liu; X Chen; Y Gu; L Zhu; Y Qian; D Pei; W Zhang; Y Shu
Journal:  Neoplasma       Date:  2015       Impact factor: 2.575

Review 4.  Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.

Authors:  Jiujie Cui; Weihua Jiang; Shuyi Wang; Liwei Wang; Keping Xie
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.

Authors:  Akihide Ryo; Hiroji Uemura; Hitoshi Ishiguro; Tatsuya Saitoh; Akira Yamaguchi; Kilian Perrem; Yoshinobu Kubota; Kun Ping Lu; Ichiro Aoki
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

6.  Pin1 overexpression in colorectal cancer and its correlation with aberrant beta-catenin expression.

Authors:  Chang-Jae Kim; Yong-Gu Cho; Yong-Gyu Park; Suk-Woo Nam; Su-Young Kim; Sug-Hyung Lee; Nam-Jin Yoo; Jung-Young Lee; Won-Sang Park
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

Review 7.  Ovarian cancer: strategies for overcoming resistance to chemotherapy.

Authors:  Roshan Agarwal; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2003-07       Impact factor: 60.716

8.  The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

Authors:  Gustavo Ayala; Dagong Wang; Gerburg Wulf; Anna Frolov; Rile Li; Janusz Sowadski; Thomas M Wheeler; Kun Ping Lu; Lere Bao
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

9.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers.

Authors:  Lere Bao; Amy Kimzey; Guido Sauter; Janusz M Sowadski; Kun Ping Lu; Da-Gong Wang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 10.  Regulation of pro-apoptotic BH3-only proteins and its contribution to cancer progression and chemoresistance.

Authors:  Jose L Fernandez-Luna
Journal:  Cell Signal       Date:  2008-05-08       Impact factor: 4.315

View more
  21 in total

Review 1.  Forkhead box M1 transcription factor: a novel target for pulmonary arterial hypertension therapy.

Authors:  Li Gu; Han-Min Liu
Journal:  World J Pediatr       Date:  2019-06-12       Impact factor: 2.764

Review 2.  'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling.

Authors:  Mei S Ong; Wanpei Cai; Yi Yuan; Hin C Leong; Tuan Z Tan; Asad Mohammad; Ming L You; Frank Arfuso; Boon C Goh; Sudha Warrier; Gautam Sethi; Nicholas S Tolwinski; Peter E Lobie; Celestial T Yap; Shing C Hooi; Ruby Y Huang; Alan P Kumar
Journal:  Br J Pharmacol       Date:  2017-08-23       Impact factor: 8.739

Review 3.  Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?

Authors:  Moein Ala; Mahan Ala
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-01

4.  Down-expression of GOLM1 enhances the chemo-sensitivity of cervical cancer to methotrexate through modulation of the MMP13/EMT axis.

Authors:  Rui Min Li; Man Man Nai; She Jiao Duan; Shu Xing Li; Bao Na Yin; Fang An; Yao Qing Zhai; Jie Liu; Yan Rong Chu; Yang Yu; Wen Yue Song
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

5.  Effects of Wnt-1 blockade in DEN-induced hepatocellular adenomas of mice.

Authors:  Argyrios Sklavos; Theofilos Poutahidis; Alexander Giakoustidis; Kali Makedou; Katerina Angelopoulou; Alexander Hardas; Paola Andreani; Argyro Zacharioudaki; George Saridis; Thomas Goulopoulos; Kalliopi Tsarea; Maria Karamperi; Vassilios Papadopoulos; Vassilios Papanikolaou; Apostolos Papalois; Stavros Iliadis; Satvinder Mudan; Daniel Azoulay; Dimitrios Giakoustidis
Journal:  Oncol Lett       Date:  2017-11-15       Impact factor: 2.967

6.  Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer.

Authors:  Sheng Li; Xiaoping Liu; Tongzu Liu; Xiangyu Meng; Xiaohong Yin; Cheng Fang; Di Huang; Yue Cao; Hong Weng; Xiantao Zeng; Xinghuan Wang
Journal:  Front Physiol       Date:  2017-11-28       Impact factor: 4.566

7.  HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway.

Authors:  Xi Xu; Yunfeng Wang; Hong Deng; Chungang Liu; Jingjing Wu; Maode Lai
Journal:  Oncotarget       Date:  2018-01-10

8.  Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis.

Authors:  Mei Chen; Yuan Zhang; Peng-Sheng Zheng
Journal:  PLoS One       Date:  2017-05-10       Impact factor: 3.240

Review 9.  Programming of Cell Resistance to Genotoxic and Oxidative Stress.

Authors:  Ilya O Velegzhaninov; Vitaly A Ievlev; Yana I Pylina; Dmitry M Shadrin; Olesya M Vakhrusheva
Journal:  Biomedicines       Date:  2018-01-02

10.  MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway.

Authors:  Wei Chen; Wei Zhao; Li Zhang; Lixin Wang; Jipeng Wang; Zongren Wan; Yongqing Hong; Liang Yu
Journal:  Oncotarget       Date:  2017-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.